| MERCK KGAA O.N. | 93.880 / +0.26% |
| Date/Time | 06/19 / 09:43 |
| Chg. / Chg.(%) | 0.240 / +0.26% |
| Bid | 93.420 / 500 |
| Ask | 93.460 / 500 |
| Open | 93.640 |
| Previous Close | 93.640 |
| High | 93.880 |
| Low | 93.380 |
| Volume [EUR] | - |
| Volume [Units] | |
| Price fixings | 3 |
| ISIN | DE0006599905 |
| Security | MRK |
| Exchange | gettex |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Xetra | 93.48 |  |
113,168 |
| Cboe Europe .. | 93.50 | |
23,092 |
| Turquoise | 93.50 | |
6,342 |
| Cboe Europe .. | 93.48 | |
3,945 |
| TradeGate | 93.540 | |
2,218 |
| Stuttgart | 93.460 | |
1,451 |
| London Inter.. | 93.32 | |
981 |
| Hamburg | 93.48 |  |
3 |
| Vienna Globa.. | 93.30 | |
0 |
| Frankfurt | 93.580 | |
0 |
| Düsseldorf | 93.44 | |
0 |
| München | 93.56 | |
0 |
| Hannover | 93.48 | |
0 |
| Berlin | 93.56 | |
0 |
| Lang & Schwa.. | 93.521 | |
|
| gettex | 93.880 | |
|
| Nasdaq Other.. | 105.5500 | |
494 |
| Borsa Italia.. | 91.42 | 287 | |
| SIX Swiss Ex.. | 101.70 | ||
| SIX Swiss Ex.. | 95.60 | ||
| EUREX | Options | ||
News
- ObsEva Progressing Toward U.S. Phase 3 Trial for Nolasiban in IVF Following Recent FDA Meeting
07:00 - GlobeNewswire - Global T-Cell Lymphoma Market to Register a CAGR of 10.6% During 2019-2024 - Chemotherapy is Expected to Hold Significant Market Share
06/18/2019 / 17:20 - GlobeNewswire - Insights Into the Worldwide Neurodegenerative Disease Market (2019-2024) by Indication Type, Drug Type and Geography
06/18/2019 / 16:08 - GlobeNewswire - Hormone Replacement Therapy Market Forecasts to 2024: Anticipating a CAGR of Approx 6.5%
06/18/2019 / 15:39 - GlobeNewswire - Merck's lung cancer treatment receives FDA approval
06/18/2019 / 13:10 - TeleTrader
Personal area
Real-timeClick on 
to activate push quotes.
to activate push quotes.